Effect of ramipril on cardiovascular events in high-risk patients. Reply

被引：0
|
作者：
Yusuf, S [1 ]
机构：
[1] McMaster Univ, Hamilton, ON L8L 2X2, Canada
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2000年 / 343卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [41] Beneficial effects of Ramipril on cardiovascular events in high-risk patients older than 75 years of age: Secondary outcomes from the HOPE trial
    Bosch, J
    Probstfield, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 154A - 154A
  • [42] Carotid intima-media thickness and risk of cardiovascular events in high-risk patients
    Kitagawa, Kazuo
    Yamagami, Hiroshi
    Hashimoto, Hiroyuki
    Itoh, Taiji
    Shimizu, Yoshiomi
    Takahashi, Daisuke
    Kondo, Kimito
    Hoshi, Taku
    Furukado, Shigetaka
    Abe, Yuko
    Sakaguchi, Manabu
    Hougaku, Hidetaka
    Matsumoto, Masayasu
    Hori, Masatsugu
    STROKE, 2007, 38 (02) : 522 - 522
  • [43] ONTARGET study of telmisartan, ramipril, or both in high-risk patients
    Ram, C. Venkata S.
    CURRENT HYPERTENSION REPORTS, 2008, 10 (05) : 345 - 348
  • [44] ONTARGET study of telmisartan, ramipril, or both in high-risk patients
    C. Venkata S. Ram
    Current Hypertension Reports, 2008, 10 : 345 - 348
  • [45] Effective prevention of cardiovascular events in high-risk patients - new indications for telmisartan
    Dziwura, Joanna
    Widecka, Krystyna
    ARTERIAL HYPERTENSION, 2010, 14 (04): : 332 - 343
  • [46] PCSK9 inhibition reduces cardiovascular events in high-risk patients
    Karina Huynh
    Nature Reviews Cardiology, 2017, 14 : 251 - 251
  • [47] Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients
    Reiter, Markus
    Effenberger, Isabella
    Sabeti, Schila
    Mlekusch, Wolfgang
    Schlager, Oliver
    Dick, Petra
    Puchner, Stefan
    Amighi, Jasmin
    Bucek, Robert A.
    Minar, Erich
    Schillinger, Martin
    RADIOLOGY, 2008, 248 (03) : 1050 - 1055
  • [48] The cardiovascular polypill in high-risk patients
    Lafeber, Melvin
    Spiering, Wilko
    Singh, Kavita
    Guggilla, Rama K.
    Patil, Vinodvenkatesh
    Webster, Ruth
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (06) : 1234 - 1242
  • [49] Ramipril and telmisartan: Equally effective for patients at high risk of vascular events?
    不详
    JOURNAL OF FAMILY PRACTICE, 2008, 57 (07): : 443 - 443
  • [50] Prophylaxis of cytomegalovirus disease in high-risk patients.
    Scholz, M
    Cinatl, J
    Doerr, W
    INFECTION, 1997, 25 (05) : 269 - 273
12345